Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

The Recent Peloton Recall Is a Buying Opportunity

By InvestorPlace Research Staff
The selloff in PTON stock is a grave overreaction. Now is a great time to dive into Peloton while shares remain depressed.

Take a Look at Ocugen’s Work on Eye Diseases, Not Just Their Vaccine Partnership

By Louis Navellier and the InvestorPlace Research Staff
With clinical data to support Ocugen's product candidate to treat multiple eye conditions, OCGN stock isn't just your typical "vaccine stock."

Vaxart’s No-Shot Vaccine Is a Potential Game Changer

By Louis Navellier and the InvestorPlace Research Staff
VXRT stock is down from its highs, but there's no need to worry, as Vaxart has a unique Covid-19 vaccine and some encouraging clinical data.

Roblox’s First Earnings Report Was Killer. So Buy the Dip in RBLX Stock.

By Luke Lango, InvestorPlace Senior Investment Analyst
Roblox is defining a new era of online gaming that will generate significant value in the long run, so buy RBLX stock.

Why Moderna Shareholders Should Savor First Quarterly Profit Results

By Louis Navellier and the InvestorPlace Research Staff
Some folks are worried about protections for vaccine-related intellectual property, but MRNA stock investors have plenty of reasons to relax.

7 Stocks to Start your Robinhood Portfolio With Just $2,000

By Josh Enomoto, InvestorPlace Contributor
Despite their reputation, Robinhood stocks to buy are surprisingly viable. Here are seven to acquire if you just have $2,000 to start.

7 of the Best Pharma Stocks to Buy Now

By Louis Navellier and the InvestorPlace Research Staff
As the market gets back to normal, it's a great time to explore the pharma stocks that got lost in the vaccine frenzy of the past year.

Walmart Stock Is A Long-Term Buy And Hold For The Ages

By Tom Kerr, InvestorPlace Contributor
Walmart stock isn't dirt cheap, but its business diversity and heavy investment spending creates a long-term opportunity.

Catch the Canopy Growth Stock With Confidence

By Nicolas Chahine, InvestorPlace Contributor
Extreme rallies and selloffs are wrong and offer investment opportunities. CGC stock is entering a zone where it makes for a good buy.

The Selloff in C3.ai Stock Presents a Solid Opportunity

By InvestorPlace Research Staff
C3.ai has a strong growth story, solid management and a big market. That drove AI stock to its highs and makes it a buy at its lows.

Amazon Stock Will Shine Post-Bezos and Post-Pandemic

By Alex Sirois, InvestorPlace Contributor
AMZN stock might look expensive with its $3k+ share price, but it'll only get more expensive moving forward.

Don’t Look Now, but Nio Stock Is Becoming an Investment Not a Trade

By Chris Markoch, InvestorPlace Contributor
NIO stock is down 30% in 2021. As investors recalibrate their expectations for the EV sector, they keep raising the bar on the Tesla of China.

4 Top Stock Trades for Tuesday: Dogecoin, TTD, CLSK, WKHS

By Bret Kenwell, InvestorPlace Contributor
Dogecoin, The Trade Desk, CleanSpark and Workhorse were our top stock trades for Tuesday. That said, let's get a look at the charts now.

7 Stocks To Buy Right Now Before They Soar on the Broader Recovery

By Faizan Farooque, InvestorPlace Contributor
We have compiled a list of the best stocks to buy right now, companies that will benefit immensely from the broader economy reopening.

Each Dip in Nvidia Stock Is a Gift for Long-Term Investors

By InvestorPlace Research Staff
NVDA stock just hit new highs, before selling pressure in other tech stocks weighed it down. Look for Nvidia to get back on track.

Is It Time for Carnival’s Investors to Abandon Ship?

By Will Ashworth, InvestorPlace Contributor
Carnival sold 40.45 million shares of CCL stock in February at $25.10 per share. The buyers of those shares have made little in the months since. 

CGC Stock: Buy The Dip In Canopy Growth

By Wayne Duggan, InvestorPlace Contributor
CGC stock is down more than 40% since mid-February. However, Canopy has been a great investment over the past year and has a bright future.

3 Momentum Stocks to Buy on Long-Term Fundamentals

By Nicolas Chahine, InvestorPlace Contributor
Momentum stocks are scary stocks to buy under duress. But that's the time to do it while others are panicking. Accumulating some makes sense.

AMC Entertainment Is On the Road to Recovery With FCF to Follow

By Mark R. Hake, CFA
AMC Entertainment will recover with FCF to follow. AMC stock is worth $15.38, or 61.7% more, using FCF forecasts and AMC’s revenue guidance.
Load More Articles